West Pharmaceutical Services earns a Buy rating with a $320 price target, reflecting ~18% upside with strong long-term growth prospects. WST's high-value product mix is expanding, driving margin ...

Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The Russell ...

Below is Validea's guru fundamental report for WEST PHARMACEUTICAL SERVICES INC (WST). Of the 22 guru strategies we follow, WST rates highest using our P/B Growth Investor model based on the published ...

We recently compiled a list of the Weak Earnings, Outlook Drag Shares of These 10 Firms on Thursday. In this article, we are going to take a look at where West Pharmaceutical Services, Inc. (NYSE:WST) ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. For the second consecutive year, U.S. equity ...

West Pharmaceutical Services stock is down 16% on deteriorating fundamentals. WST's business is contracting, with lower sales growth, compressed margins, and declining ROIC, making current valuations ...

Fintel reports that on December 12, 2024, UBS upgraded their outlook for West Pharmaceutical Services (NYSE:WST) from Neutral to Buy. As of December 3, 2024, the average one-year price target for West ...

Saturday was the day to clean the house growing up, and it was my job to clean the bathrooms. At our house, we had a bottle of Fabuloso, which was usually enough for routine cleanings, but on days ...